KIAA1143 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.334800E-01
Normal-vs-Stage2
1.738790E-01
Normal-vs-Stage3
9.420900E-04
Normal-vs-Stage4
5.087800E-01
Stage1-vs-Stage2
2.720200E-01
Stage1-vs-Stage3
2.642100E-02
Stage1-vs-Stage4
2.679000E-01
Stage2-vs-Stage3
2.901900E-02
Stage2-vs-Stage4
6.444800E-03
Stage3-vs-Stage4
1.544420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.062600E-01
Normal-vs-AfricanAmerican
4.027800E-01
Normal-vs-Asian
1.173220E-01
Caucasian-vs-AfricanAmerican
8.958400E-01
Caucasian-vs-Asian
2.113000E-01
AfricanAmerican-vs-Asian
4.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.808580E-01
Normal-vs-Female
2.592000E-01
Male-vs-Female
4.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.761800E-01
Normal-vs-Age(41-60Yrs)
3.437000E-01
Normal-vs-Age(61-80Yrs)
1.690170E-01
Normal-vs-Age(81-100Yrs)
1.098200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.117800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.223800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.624200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.861900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.783700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.061900E-02
Normal-vs-Daily Drinker
1.384970E-01
Normal-vs-Weekly Drinker
1.786420E-01
Normal-vs-Occasional Drinker
5.186800E-01
Normal-vs-Social Drinker
4.955200E-01
Non Drinker-vs-Daily Drinker
6.982400E-01
Non Drinker-vs-Weekly Drinker
5.581000E-01
Non Drinker-vs-Occasional Drinker
1.561690E-02
Non Drinker-vs-Social Drinker
4.810300E-02
Daily Drinker-vs-Weekly Drinker
8.368600E-01
Daily Drinker-vs-Occasional Drinker
7.793800E-02
Daily Drinker-vs-Social Drinker
1.599160E-01
Weekly Drinker-vs-Occasional Drinker
1.629990E-01
Weekly Drinker-vs-Social Drinker
2.784400E-01
Occasional Drinker-vs-Social Drinker
8.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.405570E-01
Normal-vs-Grade 2
4.772000E-02
Normal-vs-Grade 3
4.326100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.217600E-01
Grade 1-vs-Grade 3
7.983000E-01
Grade 1-vs-Grade 4
1.405570E-01
Grade 2-vs-Grade 3
9.273000E-01
Grade 2-vs-Grade 4
4.772000E-02
Grade 3-vs-Grade 4
4.326100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.249400E-01
Normal-vs-NonDiabetic
1.208180E-01
Diabetic-vs-NonDiabetic
8.419400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.659900E-02
Normal-vs-NoPancreatitis
1.698440E-01
Pancreatitis-vs-NoPancreatitis
5.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.473000E-01
Normal-vs-N1
1.988630E-01
N0-vs-N1
8.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.089200E-01
Normal-vs-TP53-NonMutant
4.790600E-01
TP53-Mutant-vs-TP53-NonMutant
9.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
